{
  "schema_version": "0.1.0",
  "case_id": "HR-NI032",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "NI032",
    "display_name": "Swami Vivekananda",
    "aliases": [
      "Narendranath Datta",
      "Narendra Nath Datta"
    ],
    "name_parts": {
      "given": [],
      "family": "Vivekananda",
      "family_first": false
    },
    "sex": "male",
    "era": "19th Century",
    "nationality": "Indian",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1863-01-12",
          "display": "January 12, 1863",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1863",
              "display": "1863",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0012"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the Belur Math biography."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1902-07-04",
          "display": "July 4, 1902",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1902",
              "display": "1902",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0012"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-NI032-SYN",
      "ssn": "000-32-9014",
      "date_of_birth": "1991-01-12",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Anjali Thornbury-Mensah, MD",
      "fictional_consultant": {
        "name": "Rohan Lindqvist-Bose, MD",
        "specialty": "Endocrinology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1863-01-12",
        "display": "January 12, 1863",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born Narendranath Datta in Calcutta.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1881-11",
        "display": "November 1881",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Meets Sri Ramakrishna; takes monastic vows in 1887.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1893-09",
        "display": "September 1893",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Speaks at the World's Parliament of Religions in Chicago; teaches in the West until 1897.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1897-03",
        "display": "March 1897",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Writes that he has diabetes; goes to Darjeeling on his physicians' advice.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1897-05-01",
        "display": "May 1, 1897",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Founds the Ramakrishna Mission Association; writes of lifelong trouble falling asleep.",
      "claim_ids": [
        "CLM-0004",
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1898-03-30",
        "display": "March 30, 1898",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Leaves for Darjeeling; plague relief in Calcutta; travels north from May 11.",
      "claim_ids": [
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1898-10-18",
        "display": "October 18, 1898",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Returns to Belur pallid and ill, with suffocating attacks of asthma.",
      "claim_ids": [
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1899-01-26",
        "display": "January 26, 1899",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Writes that the diabetes has gone and asthma has come in its place.",
      "claim_ids": [
        "CLM-0009",
        "CLM-0014"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1899-06",
        "display": "June 1899",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Second visit to the West, returning to the Belur Math in December 1900.",
      "claim_ids": [
        "CLM-0010"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1901-12-12",
        "display": "December 12, 1901",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Writes of albuminuria for three years and a bleed in the right eye; asthma, diabetes and dropsy in his last illness.",
      "claim_ids": [
        "CLM-0011",
        "CLM-0012",
        "CLM-0015"
      ]
    },
    {
      "event_id": "EVT-0011",
      "date": {
        "iso": "1902-07-04",
        "display": "July 4, 1902",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies at the Belur Math at 39.",
      "claim_ids": [
        "CLM-0013",
        "CLM-0016"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "He was born Narendranath (Narendra Nath) Datta in an affluent family in Calcutta (Kolkata) on 12 January 1863. His father, Vishwanath Datta, was a successful attorney; his mother was Bhuvaneshwari Devi.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented date used for the synthetic date of birth.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "born in an affluent family in Kolkata on 12 January 1863 ... Narendra Nath Datta ... Vishwanath Datta, was a successful attorney ... Bhuvaneshwari Devi"
        },
        {
          "source_id": "SRC-0012",
          "relationship": "context",
          "locator": "roster birth date"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "He met Sri Ramakrishna at Dakshineswar in November 1881 and became his disciple; in 1887 he and his brother disciples took the formal vows of sannyasa and new monastic names.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern social history: a Hindu monk living by monastic vows.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "first met Sri Ramakrishna at Dakshineshwar in November 1881 ... in 1887 they took the formal vows of sannyasa, thereby assuming new names"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "He left Bombay for America on 31 May 1893 and spoke at the World's Parliament of Religions in Chicago in September 1893, which made him famous; he then spent nearly three and a half years teaching Vedanta, mostly in the eastern United States and London, and returned to India in January 1897.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern social history: an internationally known teacher who travels and lectures.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "He left Mumbai for America on 31 May 1893 ... the World's Parliament of Religions ... nearly three and a half years ... returned to India in January 1897"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "On 1 May 1897, at a meeting of the monastic and lay devotees of Sri Ramakrishna in Calcutta, he founded the Ramakrishna Mission Association; in February 1898 the monastery moved to a garden house at Belur on the west bank of the Ganga, and land for the Belur Math was bought in early 1898.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern social history: head of a monastic order and its service mission, living at the monastery by the river near Calcutta.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "He founded on 1 May 1897 a unique type of organization ... Ramakrishna Mission ... In early 1898 he acquired a big plot of land on the western bank of the Ganga at a place called Belur"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "On May 1, 1897, Swami Vivekananda called a meeting of the monastic and lay devotees ... the Ramakrishna Mission Association came into existence"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "In February 1898, the monastery was removed from Alambazar to Nilambar Mukherjee's garden house in the village of Belur"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "In March and April 1897, soon after his return to India, he wrote that he had diabetes. On 16 March he wrote: \"The work has broken me down completely, and I have got 'diabetes', an incurable disease\"; on 26 March: \"The result of this steady work in the West and the tremendous work of a month in India upon the Bengalee constitution is 'diabetes'. It is a hereditary foe,\" adding that \"Eating only meat and drinking no water seems to be the only way to prolong life\"; and on 7 April that he had been \"attacked by 'Diabetes', a fell disease\" and had gone to Darjeeling, cool and \"very good for the disease,\" where the doctors did not want him to move about. A biography says he went to Darjeeling on the advice of physicians.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented diabetes, at about 34, to which the modern diagnosis is linked. He called it hereditary; no relative is named. How the diagnosis was made is not recorded (urine sugar is likely but not stated).",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "The work has broken me down completely, and I have got diabetes, an incurable disease, which must carry me off at least in a few years"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "The result of this steady work in the West and the tremendous work of a month in India upon the Bengalee constitution is diabetes. It is a hereditary foe ... Eating only meat and drinking no water seems to be the only way to prolong life"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports",
          "locator": "I have been attacked by Diabetes, a fell disease ... Darjeeling, it being very cool and very good for the disease ... the doctors therefore do not want me to move about"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "The strain of work and the heat of the plains soon told upon his health. At the advice of physicians he went for a short change to Darjeeling"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "On 29 May 1897, from Almora, he wrote to a physician disciple that he was taking the medicines sent to him, riding morning and evening and feeling very strong, but that \"I never in my life could sleep as soon as I got into bed. I must toss for at least two hours,\" that he felt hot after the evening meal, that \"There has not been any thirst even though the days are fearfully hot,\" and that he was afraid of \"getting fat on a too much milk diet.\"",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "His own account of lifelong difficulty falling asleep, linked to the modern insomnia; and of thirst as a symptom he watched for.",
      "source_links": [
        {
          "source_id": "SRC-0008",
          "relationship": "supports",
          "locator": "I never in my life could sleep as soon as I got into bed. I must toss for at least two hours ... There has not been any thirst even though the days are fearfully hot ... I am afraid I am getting fat on a too much milk diet"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "In 1898 he went to Darjeeling on 30 March for the cool air, came down to Calcutta to organize relief during an outbreak of plague, and left on 11 May for Nainital, Almora and Kashmir.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only, after the true-frame index date; it explains the long gap in the modern visits.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "on March 30, 1898, the Swami left for Darjeeling ... he had to come down to Calcutta, where an outbreak of plague was striking terror ... the Swami left Calcutta for Nainital on May 11"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "He returned to Belur on 18 October 1898. His brother disciples saw that he was \"very pallid and ill. He suffered from suffocating attacks of asthma; when he emerged from its painful fits, his face looked blue, like that of a drowning man.\"",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only, after the true-frame index date; the documented asthma to which the modern sick visit and asthma diagnosis are linked.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "arrived at Belur on October 18. His brother disciples saw that he was very pallid and ill. He suffered from suffocating attacks of asthma; when he emerged from its painful fits, his face looked blue, like that of a drowning man"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "On 26 January 1899 he wrote from the Belur Math: \"The old diabetes has now disappeared. In its place has come what some doctors call asthma, others dyspepsia, owing to nervous prostration. However, it is a most worrying disease, giving one the sensation of suffocation - sometimes for days.\"",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only, after the true-frame index date.",
      "source_links": [
        {
          "source_id": "SRC-0009",
          "relationship": "supports",
          "locator": "The old diabetes has now disappeared. In its place has come what some doctors call asthma, others dyspepsia, owing to nervous prostration. However, it is a most worrying disease, giving one the sensation of suffocation sometimes for days"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "He made a second visit to the West from June 1899 and returned to the Belur Math in December 1900.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only, after the true-frame index date.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "In June 1899 he went to the West on a second visit ... returned to Belur Math in December 1900"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "In 1901 he wrote that \"Bengal brings the asthma now and then\" and that \"the terrible things - Bright's disease and diabetes - have disappeared altogether\" (2 September), and later (12 December) that \"the last three years I have been getting albuminuria now and then,\" that the kidneys were \"structurally all right,\" that a cold always increased it, and that \"a small blood vessel in the right eye\" had burst; his doctors put him to bed and forbade meat.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only, after the true-frame index date. His own reports of albuminuria from about 1898, of a diagnosis of Bright's disease, and of a bleed in the right eye.",
      "source_links": [
        {
          "source_id": "SRC-0010",
          "relationship": "supports",
          "locator": "Of course, Bengal brings the asthma now and then, but it is getting tame, and the terrible things Bright's disease and diabetes have disappeared altogether"
        },
        {
          "source_id": "SRC-0011",
          "relationship": "supports",
          "locator": "the last three years I have been getting albuminuria now and then. It is not constant ... The kidneys are structurally all right ... Catching cold always increases it. This time it has caused a small blood vessel in the right eye to burst"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0012",
      "statement": "According to a biography by a monk of his order, in March 1901 he was \"suffering from both asthma and diabetes\"; in the last year and a half of his life \"Diabetes took the form of dropsy. His feet swelled ... He could hardly close his eyes in sleep,\" and on a physician's strict regimen he avoided water and salt, for twenty-one days taking no water at all.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "History only, after the true-frame index date. The biographer's description of his last illness; the cause of the swelling is not recorded.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "He was in poor health, suffering from both asthma and diabetes ... Diabetes took the form of dropsy. His feet swelled and certain parts of his body became hypersensitive. He could hardly close his eyes in sleep. A native physician made him follow a very strict regime: he had to avoid water and salt. For twenty-one days he did not allow a drop of water to pass through his throat"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0013",
      "statement": "He died at the Belur Math on the night of 4 July 1902, at 39, after an hour of meditation; a brother monk recalled \"a little blood in his nostrils, about his mouth, and in his eyes.\" The physicians gave the cause as \"apoplexy or sudden failure of the heart\"; the monks held that he had left his body in samadhi.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only, stated without detail and with respect for the monks' understanding of his death.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "a little blood in his nostrils, about his mouth, and in his eyes ... Swami Vivekananda passed away at the age of thirty-nine years ... the cause, according to medical science, having been apoplexy or sudden failure of the heart. But the monks were convinced that their leader had voluntarily cast off his body in samadhi"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "the end came quietly on the night of 4 July 1902"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0014",
      "statement": "Retrospective interpretation: diabetes beginning at about 34 in a man of South Asian ancestry who called it hereditary, who lived five more years without insulin, and whose thirst and sugar came and went with diet and rest, is most consistent with type 2 diabetes; slowly progressive autoimmune diabetes cannot be excluded from the record.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "Retrospective; the modern classification is synthetic.",
      "source_links": [
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "It is a hereditary foe"
        },
        {
          "source_id": "SRC-0009",
          "relationship": "supports",
          "locator": "The old diabetes has now disappeared"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "context",
          "locator": "suffering from both asthma and diabetes"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0015",
      "statement": "Retrospective interpretation: albuminuria from about 1898, a diagnosis of Bright's disease, a bleed in the eye and swelling of the feet late in his life are consistent with diabetic kidney disease, perhaps with high blood pressure, but no measurement survives and other kidney or heart disease cannot be excluded.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "Retrospective; the modern albuminuria and diabetic kidney disease are synthetic.",
      "source_links": [
        {
          "source_id": "SRC-0011",
          "relationship": "supports",
          "locator": "the last three years I have been getting albuminuria now and then"
        },
        {
          "source_id": "SRC-0010",
          "relationship": "supports",
          "locator": "Bright's disease and diabetes"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Diabetes took the form of dropsy"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0016",
      "statement": "Retrospective interpretation: his sudden death, which many accounts describe as the rupture of a blood vessel in the brain, could have been a brain hemorrhage or a heart event; the physicians' \"apoplexy or sudden failure of the heart\" does not decide between them, and his followers understand it as samadhi.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "Retrospective and disputed; not used in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "apoplexy or sudden failure of the heart"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Swami Vivekananda",
      "publisher": "Belur Math (Ramakrishna Math and Ramakrishna Mission)",
      "url": "https://belurmath.org/swami-vivekananda/",
      "source_type": "biography",
      "accessed": "2026-11-06",
      "rights_note": "Biography on the order's official site; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Nikhilananda S. Vivekananda: A Biography. Chapter: Return to India",
      "publisher": "Ramakrishna-Vivekananda Center of New York (via ramakrishnavivekananda.info)",
      "url": "https://www.ramakrishnavivekananda.info/vivekananda_biography/10_return.htm",
      "source_type": "biography",
      "published": "1953",
      "accessed": "2026-11-06",
      "rights_note": "Biography by a monk of the Ramakrishna Order; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Nikhilananda S. Vivekananda: A Biography. Chapter: In Northern India",
      "publisher": "Ramakrishna-Vivekananda Center of New York (via ramakrishnavivekananda.info)",
      "url": "https://www.ramakrishnavivekananda.info/vivekananda_biography/11_northern_india.htm",
      "source_type": "biography",
      "published": "1953",
      "accessed": "2026-11-06",
      "rights_note": "Biography by a monk of the Ramakrishna Order; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Nikhilananda S. Vivekananda: A Biography. Chapter: Towards the End",
      "publisher": "Ramakrishna-Vivekananda Center of New York (via ramakrishnavivekananda.info)",
      "url": "https://www.ramakrishnavivekananda.info/vivekananda_biography/13_towards_the_end.htm",
      "source_type": "biography",
      "published": "1953",
      "accessed": "2026-11-06",
      "rights_note": "Biography by a monk of the Ramakrishna Order; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Vivekananda S. Letter to Sister Christine, Darjeeling, 16 March 1897 (Complete Works, vol. 9, Letters, Fifth Series, CV)",
      "publisher": "Advaita Ashrama (Complete Works), via Wikisource",
      "url": "https://en.wikisource.org/wiki/The_Complete_Works_of_Swami_Vivekananda/Volume_9/Letters_-_Fifth_Series/CV_Christina",
      "source_type": "primary",
      "accessed": "2026-11-06",
      "rights_note": "His own letter; short quotations used with citation."
    },
    {
      "source_id": "SRC-0006",
      "title": "Vivekananda S. Letter to Mrs. Ole Bull, 26 March 1897 (Complete Works, vol. 9, Letters, Fifth Series, CVI)",
      "publisher": "Advaita Ashrama (Complete Works), via Wikisource",
      "url": "https://en.wikisource.org/wiki/The_Complete_Works_of_Swami_Vivekananda/Volume_9/Letters_-_Fifth_Series/CVI_Mrs._Bull%E2%80%94",
      "source_type": "primary",
      "accessed": "2026-11-06",
      "rights_note": "His own letter; short quotations used with citation."
    },
    {
      "source_id": "SRC-0007",
      "title": "Vivekananda S. Letter to Lala Badri Sah, Darjeeling, 7 April 1897 (Complete Works, vol. 9, Letters, Fifth Series, CIX)",
      "publisher": "Advaita Ashrama (Complete Works), via Wikisource",
      "url": "https://en.wikisource.org/wiki/The_Complete_Works_of_Swami_Vivekananda/Volume_9/Letters_-_Fifth_Series/CIX_Lalajee",
      "source_type": "primary",
      "accessed": "2026-11-06",
      "rights_note": "His own letter; short quotations used with citation."
    },
    {
      "source_id": "SRC-0008",
      "title": "Vivekananda S. Letter to Dr. Shashi Bhushan Ghosh, Almora, 29 May 1897 (Complete Works, vol. 5, Epistles, First Series, LXXV)",
      "publisher": "Advaita Ashrama (Complete Works), via Wikisource",
      "url": "https://en.wikisource.org/wiki/The_Complete_Works_of_Swami_Vivekananda/Volume_5/Epistles_-_First_Series/LXXV_Doctor_Shashi",
      "source_type": "primary",
      "accessed": "2026-11-06",
      "rights_note": "His own letter; short quotations used with citation."
    },
    {
      "source_id": "SRC-0009",
      "title": "Vivekananda S. Letter to Sister Christine, Belur Math, 26 January 1899 (Complete Works, vol. 9, Letters, Fifth Series, CXXXII)",
      "publisher": "Advaita Ashrama (Complete Works), via Wikisource",
      "url": "https://en.wikisource.org/wiki/The_Complete_Works_of_Swami_Vivekananda/Volume_9/Letters_-_Fifth_Series/CXXXII_Christina",
      "source_type": "primary",
      "accessed": "2026-11-06",
      "rights_note": "His own letter; short quotations used with citation."
    },
    {
      "source_id": "SRC-0010",
      "title": "Vivekananda S. Letter to Sister Christine, Belur Math, 2 September 1901 (Complete Works, vol. 9, Letters, Fifth Series, CCIII)",
      "publisher": "Advaita Ashrama (Complete Works), via Wikisource",
      "url": "https://en.wikisource.org/wiki/The_Complete_Works_of_Swami_Vivekananda/Volume_9/Letters_-_Fifth_Series/CCIII_Christine",
      "source_type": "primary",
      "accessed": "2026-11-06",
      "rights_note": "His own letter; short quotations used with citation."
    },
    {
      "source_id": "SRC-0011",
      "title": "Vivekananda S. Letter to Sister Christine, Belur Math, 12 December 1901 (Complete Works, vol. 9, Letters, Fifth Series, CCXI)",
      "publisher": "Advaita Ashrama (Complete Works), via Wikisource",
      "url": "https://en.wikisource.org/wiki/The_Complete_Works_of_Swami_Vivekananda/Volume_9/Letters_-_Fifth_Series/CCXI_Christine",
      "source_type": "primary",
      "accessed": "2026-11-06",
      "rights_note": "His own letter; short quotations used with citation."
    },
    {
      "source_id": "SRC-0012",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-06",
      "accessed": "2026-11-06",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-02-09",
    "index_age": 35,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Diagnose and classify diabetes in a 35-year-old South Asian man at a near-normal BMI (ADA screens Asian Americans from a BMI of 23 because South Asians develop type 2 diabetes at lower weights and younger ages): confirm with A1c and fasting glucose, test GAD antibodies and C-peptide to exclude type 1 and slowly progressive autoimmune diabetes, and record the decision. Then treat by shared decision with metformin and, once moderately increased albuminuria is confirmed, an SGLT2 inhibitor; build a mostly vegetarian, culturally fitting nutrition plan with a dietitian around his monastic diet; plan safe religious fasting with medication adjustment (IDF-DAR guidance, adapted from Ramadan to Hindu fasts); screen and protect the kidneys (UACR, eGFR, blood pressure with an ARB), eyes and lipids; treat long-standing insomnia without hypnotics; and diagnose and treat adult-onset asthma on GINA track 1, managing the steroid-induced hyperglycemia of an exacerbation. His diet, fasting and monastic practice are his to decide; the clinic adapts to them.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-02-09",
        "purpose": "New patient visit for thirst, frequent urination, tiredness and weight loss in a 35-year-old monk told of diabetes a year ago and never tested: examination, random glucose and urine tests, and planning of fasting tests to confirm and classify diabetes; long-standing insomnia; raised blood pressure"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-02-16",
        "purpose": "Diagnosis visit with the endocrinology consultation: A1c, fasting glucose, GAD antibodies, C-peptide, urine albumin, lipids and B12; type 2 diabetes confirmed; metformin by shared decision; nutrition and fasting plans"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-03-09",
        "purpose": "Periodic preventive visit"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-03-23",
        "purpose": "Five-week diabetes review before a long journey: glucose log, metformin dose, kidney function and potassium on losartan, repeat urine albumin, retinal photographs, statin, and a travel and fasting plan"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-10-20",
        "purpose": "Same-day sick visit for an asthma attack after returning from the mountains"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-10-27",
        "purpose": "Review after seven months away and a week after an asthma attack: A1c, kidneys, lipids, spirometry with bronchodilator response and FeNO; asthma and diabetic kidney disease confirmed; empagliflozin and maintenance-and-reliever inhaler; fasting plan for the coming festival"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Thirst, frequent urination day and night, tiredness and about 4 kg weight loss over two months, with a random glucose of 246 mg/dL; told by physicians a year ago that he had diabetes, never confirmed with modern tests or treated except by diet. Diabetes to be confirmed and classified (type 2, type 1 or slowly progressive autoimmune diabetes) with A1c, fasting glucose, GAD antibodies and C-peptide",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R73.9",
            "display": "Hyperglycemia, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic presenting problem anchored to his documented diabetes of the year before. Superseded by the diagnosis at the second visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-02-16"
      },
      {
        "id": "PRB-002",
        "display": "Type 2 diabetes: A1c 9.4 percent and fasting glucose 172 mg/dL, with symptoms; GAD65 antibodies negative and fasting C-peptide preserved (2.6 ng/mL); no ketones. BMI 24.6, in the range where ADA screens Asian Americans. Classified as type 2, not type 1 or slowly progressive autoimmune diabetes",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E11.65",
            "display": "Type 2 diabetes mellitus with hyperglycemia",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic modern confirmation and classification linked to his documented diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-02-16"
      },
      {
        "id": "PRB-003",
        "display": "Moderately increased albuminuria on a first sample (urine albumin-to-creatinine ratio 46 mg/g), eGFR normal; to be confirmed on two of three samples over three to six months",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R80.9",
            "display": "Proteinuria, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011",
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic finding linked to his documented albuminuria; superseded when diabetic kidney disease was confirmed.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-02-16",
        "abatement_date": "2026-10-27"
      },
      {
        "id": "PRB-004",
        "display": "Raised blood pressure in clinic (138/86, average of two readings) without a diagnosis of hypertension; home readings to be taken",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R03.0",
            "display": "Elevated blood-pressure reading, without diagnosis of hypertension",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic finding; not a claim about his real blood pressure.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-03-09"
      },
      {
        "id": "PRB-005",
        "display": "Hypertension, stage 1: clinic 138/86, 136/86 and 134/84; home average 136/86 over seven days; with moderately increased albuminuria and diabetes",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I10",
            "display": "Essential (primary) hypertension",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic finding of the modern episode; not a claim about his real blood pressure, which was never recorded.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-03-09"
      },
      {
        "id": "PRB-006",
        "display": "Long-standing difficulty falling asleep: by his own account he has never been able to fall asleep on getting into bed and lies awake for two hours or more most nights; worse lately with waking to pass urine; rises before dawn for meditation",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G47.00",
            "display": "Insomnia, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern problem linked to his documented lifelong difficulty falling asleep.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-007",
        "display": "Mixed hyperlipidemia: LDL cholesterol 132 mg/dL, triglycerides 228, HDL 36",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E78.2",
            "display": "Mixed hyperlipidemia",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cardiovascular risk factor.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-02-16"
      },
      {
        "id": "PRB-008",
        "display": "Attacks of wheeze and breathlessness for three weeks since coming down from the mountains to the damp plains, the worst last night with a sense of suffocation: peak flow 330 L/min (56 percent of predicted), oxygen saturation 94 percent, rising to 410 L/min after bronchodilator; no fever, edema or chest pain; chest X-ray and ECG without heart failure or pneumonia. Asthma to be confirmed with spirometry",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R06.2",
            "display": "Wheezing",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic presenting problem anchored to his documented suffocating attacks of asthma on his return to Belur. Superseded by the diagnosis a week later.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-10-20",
        "abatement_date": "2026-10-27"
      },
      {
        "id": "PRB-009",
        "display": "Asthma, adult onset, confirmed: FEV1 2.95 L (77 percent predicted) rising 470 mL (16 percent) after bronchodilator, FEV1/FVC 0.66 rising to 0.75; FeNO 44 ppb; brought on by damp air and smoke; one moderate attack treated with prednisone",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "J45.40",
            "display": "Moderate persistent asthma, uncomplicated",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern confirmation linked to his documented attacks of asthma.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-10-27"
      },
      {
        "id": "PRB-010",
        "display": "Diabetic kidney disease, CKD stage G1 A2: moderately increased albuminuria on three samples over eight months (46, 41 and 34 mg/g) with eGFR above 90",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E11.21",
            "display": "Type 2 diabetes mellitus with diabetic nephropathy",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011",
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic modern diagnosis linked to his documented albuminuria and Bright's disease; not a claim about the cause of his real kidney disease.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-10-27"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Metformin extended-release 500 mg tablets: two tablets (1000 mg) with the evening meal, starting with one for the first week",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "860975",
            "display": "24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1000,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "1000 mg with the evening meal"
        },
        "start_date": "2026-02-16",
        "end_date": "2026-03-23",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic first-line glucose-lowering treatment chosen by shared decision; taken with the evening meal so that it fits fast days.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Metformin extended-release 500 mg tablets: four tablets (2000 mg) with the evening meal; on fast days with the meal that ends the fast; hold if vomiting, diarrhea or unable to drink",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "860975",
            "display": "24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 2000,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "2000 mg with the evening meal"
        },
        "start_date": "2026-03-23",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic titration to the full dose.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Losartan 25 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "979485",
            "display": "losartan potassium 25 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 25,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-03-09",
        "indication_problem_ids": [
          "PRB-005",
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic angiotensin receptor blocker for hypertension with albuminuria in diabetes; an ACE inhibitor's cough was avoided.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Atorvastatin 10 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "617312",
            "display": "atorvastatin 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 10,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-03-23",
        "indication_problem_ids": [
          "PRB-007"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic moderate-intensity statin at 35 with diabetes, South Asian ancestry, albuminuria and hypertension, by his choice.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Prednisone 20 mg oral tablet, two tablets (40 mg) each morning for five days",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312615",
            "display": "prednisone 20 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 40,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "40 mg each morning for five days"
        },
        "start_date": "2026-10-20",
        "end_date": "2026-10-24",
        "indication_problem_ids": [
          "PRB-008"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic short oral corticosteroid course for a moderate attack, with glucose monitoring.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Budesonide-formoterol 160/4.5 mcg inhaler with a spacer, one inhalation as needed for wheeze or breathlessness, no more than 12 inhalations a day, until lung function testing",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1246304",
            "display": "120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "{inhalation}"
        },
        "route": "inhalation",
        "frequency": {
          "period": 4,
          "period_unit": "h",
          "text": "One inhalation as needed"
        },
        "start_date": "2026-10-20",
        "end_date": "2026-10-27",
        "as_needed": true,
        "indication_problem_ids": [
          "PRB-008"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic anti-inflammatory reliever started at the attack, before formal testing.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Empagliflozin 10 mg oral tablet, one tablet each morning; skip it on any day of fasting without water, and stop it when unable to eat or drink",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1545658",
            "display": "empagliflozin 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 10,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-10-27",
        "indication_problem_ids": [
          "PRB-010",
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011",
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic SGLT2 inhibitor for diabetic kidney disease with persistent albuminuria, with fasting and sick-day rules.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "MED-009",
        "display": "Budesonide-formoterol 160/4.5 mcg inhaler with a spacer as maintenance and reliever (GINA track 1, step 3): one inhalation twice daily and one as needed, no more than 12 inhalations a day",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1246304",
            "display": "120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "{inhalation}"
        },
        "route": "inhalation",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One inhalation twice daily plus one as needed"
        },
        "start_date": "2026-10-27",
        "indication_problem_ids": [
          "PRB-009"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic maintenance-and-reliever therapy for adult-onset asthma.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose (random)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 246,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 139,
          "text": "Random sample; 200 mg/dL or more with symptoms suggests diabetes"
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic random venous glucose at presentation with thirst and frequent urination. No result from his life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 136,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic basic chemistry at presentation. No result from his life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 4.3,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic basic chemistry at presentation. No result from his life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 0.96,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic basic chemistry at presentation. No result from his life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 106,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic basic chemistry at presentation. No result from his life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 14.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.5,
          "high": 17.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hemoglobin at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V1",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-02-09",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen at presentation; negative. Not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-03-09",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen (minimal; item 9 scored 0; the points are for sleep and tiredness); not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V3",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-03-09",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic anxiety screen (minimal).",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V3",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-03-09",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen; he does not drink, by his vows.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "OBS-PEF-V5",
        "display": "Maximum expiratory gas flow Respiratory system airway by Peak flow meter",
        "label": "Peak expiratory flow",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-10-20",
        "value": 330,
        "unit": "L/min",
        "reference_range": {
          "low": 470,
          "text": "80 percent of his predicted 590 L/min"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19935-6",
            "display": "Maximum expiratory gas flow Respiratory system airway by Peak flow meter",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic peak flow on arrival; 410 L/min an hour after treatment (in note text).",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V2",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 9.4,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 6.5% or more diabetes; his target below 7%"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic A1c confirming diabetes. Synthetic value; no result from his life is known.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V2",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose (fasting)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 172,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99,
          "text": "Fasting; 126 mg/dL or more indicates diabetes"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic fasting plasma glucose confirming diabetes. Synthetic value; no result from his life is known.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD-V2",
        "display": "Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay",
        "label": "GAD65 antibodies",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 1.2,
        "unit": "[IU]/mL",
        "reference_range": {
          "high": 5,
          "text": "Below 5 IU/mL negative"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "56540-8",
            "display": "Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic GAD65 antibodies, negative: against type 1 and slowly progressive autoimmune diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-CPEP-V2",
        "display": "C peptide [Mass/volume] in Serum or Plasma",
        "label": "C-peptide (fasting)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 2.6,
        "unit": "ng/mL",
        "reference_range": {
          "low": 0.8,
          "high": 3.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1986-9",
            "display": "C peptide [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic fasting C-peptide, preserved (with glucose 172 mg/dL): insulin secretion is present.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V2",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 46,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "30 to 299 moderately increased; 300 or more severely increased"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011",
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic first urine albumin-to-creatinine ratio, moderately increased; to be confirmed.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V2",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 214,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "H",
        "panel": {
          "code": "57698-3",
          "display": "Lipid panel with direct LDL - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting lipid panel at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V2",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 36,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40,
          "text": "40 mg/dL or more for men"
        },
        "interpretation": "L",
        "panel": {
          "code": "57698-3",
          "display": "Lipid panel with direct LDL - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting lipid panel at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V2",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 228,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "H",
        "panel": {
          "code": "57698-3",
          "display": "Lipid panel with direct LDL - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting lipid panel at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V2",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 132,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "57698-3",
          "display": "Lipid panel with direct LDL - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting lipid panel at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V2",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 38,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ALT at diagnosis; FIB-4 low (in note text).",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V2",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 1.8,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic TSH at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-B12-V2",
        "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
        "label": "Vitamin B12",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 312,
        "unit": "pg/mL",
        "reference_range": {
          "low": 232,
          "high": 1245
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2132-9",
            "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline vitamin B12 before long-term metformin in a man who eats mostly vegetarian food.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V4",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-23",
        "value": 4.6,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and kidney function two weeks after starting losartan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-23",
        "value": 1.0,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and kidney function two weeks after starting losartan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-23",
        "value": 101,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and kidney function two weeks after starting losartan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V4",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-23",
        "value": 41,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "30 to 299 moderately increased; 300 or more severely increased"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011",
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic second urine albumin-to-creatinine ratio, moderately increased.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V6",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 6.9,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 6.5% or more diabetes; his target below 7%"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic A1c on metformin after seven months; at target.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V6",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose (fasting)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 124,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99,
          "text": "Fasting; 126 mg/dL or more indicates diabetes"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic fasting plasma glucose, two days after the prednisone course ended.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V6",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 34,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "30 to 299 moderately increased; 300 or more severely increased"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011",
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic third urine albumin-to-creatinine ratio: moderately increased albuminuria persisting for more than three months.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V6",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 4.5,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and kidney function on losartan, before starting empagliflozin.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V6",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 0.98,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and kidney function on losartan, before starting empagliflozin.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V6",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 103,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and kidney function on losartan, before starting empagliflozin.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V6",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 152,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "panel": {
          "code": "57698-3",
          "display": "Lipid panel with direct LDL - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel seven months after starting atorvastatin (later than the protocol's four to twelve weeks).",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V6",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 39,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40,
          "text": "40 mg/dL or more for men"
        },
        "interpretation": "L",
        "panel": {
          "code": "57698-3",
          "display": "Lipid panel with direct LDL - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel seven months after starting atorvastatin (later than the protocol's four to twelve weeks).",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V6",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 146,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "panel": {
          "code": "57698-3",
          "display": "Lipid panel with direct LDL - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel seven months after starting atorvastatin (later than the protocol's four to twelve weeks).",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V6",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 84,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "57698-3",
          "display": "Lipid panel with direct LDL - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel seven months after starting atorvastatin (later than the protocol's four to twelve weeks).",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-FEV1PRE-V6",
        "display": "FEV1 --pre bronchodilation",
        "label": "FEV1 before bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-10-27",
        "value": 2.95,
        "unit": "L",
        "reference_range": {
          "low": 3.1,
          "text": "Lower limit of normal; predicted 3.85 L; lower limit of normal 3.10 L (GLI Global race-neutral equations)"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20157-4",
            "display": "FEV1 --pre bronchodilation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic lung function a week after the attack (formoterol held for 24 hours): obstruction reversing by 470 mL (16 percent), with raised FeNO.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-FEV1POST-V6",
        "display": "FEV1 --post bronchodilation",
        "label": "FEV1 after bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-10-27",
        "value": 3.42,
        "unit": "L",
        "reference_range": {
          "low": 3.1,
          "text": "Lower limit of normal; predicted 3.85 L; lower limit of normal 3.10 L (GLI Global race-neutral equations)"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20155-8",
            "display": "FEV1 --post bronchodilation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic lung function a week after the attack (formoterol held for 24 hours): obstruction reversing by 470 mL (16 percent), with raised FeNO.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-FEV1P-V6",
        "display": "FEV1 measured/predicted",
        "label": "FEV1 percent predicted before bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-10-27",
        "value": 77,
        "unit": "%",
        "reference_range": {
          "low": 80,
          "text": "GLI Global race-neutral equations"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20152-5",
            "display": "FEV1 measured/predicted",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic lung function a week after the attack (formoterol held for 24 hours): obstruction reversing by 470 mL (16 percent), with raised FeNO.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-RATIOPRE-V6",
        "display": "FEV1/FVC",
        "label": "FEV1/FVC before bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-10-27",
        "value": 0.66,
        "unit": "{ratio}",
        "reference_range": {
          "low": 0.7,
          "text": "Lower limit of normal for his age (GLI Global)"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19926-5",
            "display": "FEV1/FVC",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic lung function a week after the attack (formoterol held for 24 hours): obstruction reversing by 470 mL (16 percent), with raised FeNO.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-RATIOPOST-V6",
        "display": "FEV1/FVC --post bronchodilation",
        "label": "FEV1/FVC after bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-10-27",
        "value": 0.75,
        "unit": "{ratio}",
        "reference_range": {
          "low": 0.7,
          "text": "Lower limit of normal for his age (GLI Global)"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "69970-2",
            "display": "FEV1/FVC --post bronchodilation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic lung function a week after the attack (formoterol held for 24 hours): obstruction reversing by 470 mL (16 percent), with raised FeNO.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-FENO-V6",
        "display": "Fractional concentration of exhaled nitric oxide",
        "label": "FeNO",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-10-27",
        "value": 44,
        "unit": "[ppb]",
        "reference_range": {
          "high": 25,
          "text": "Above 50 ppb high; 25 to 50 intermediate (ATS)"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "96269-6",
            "display": "Fractional concentration of exhaled nitric oxide",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic lung function a week after the attack (formoterol held for 24 hours): obstruction reversing by 470 mL (16 percent), with raised FeNO.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-ACT-V6",
        "display": "Total score [ACT]",
        "label": "Asthma Control Test",
        "status": "final",
        "effective_date": "2026-10-27",
        "value": 15,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "82668-5",
            "display": "Total score [ACT]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic Asthma Control Test covering the last four weeks, which include the attack.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V6",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-10-27",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Comprehensive diabetic foot examination: skin intact; pulses present; 10-g monofilament and vibration sense normal at all sites",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "401191002",
            "display": "Diabetic foot examination",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-02-16",
          "end": "2026-02-16"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic foot examination at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Diabetes self-management education and medical nutrition therapy referral: a dietitian visit to build a meal plan around his monastery diet and fasts",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "385804009",
            "display": "Diabetic care",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-02-16",
          "end": "2026-02-16"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic education referral at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Advance care planning conversation, about 20 minutes, with his consent",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-03-09",
          "end": "2026-03-09"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only his own general preferences.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Diabetic retinopathy screening with retinal photographs of both eyes: no retinopathy; no macular edema",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "134395001",
            "display": "Diabetic retinopathy screening",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-03-23",
          "end": "2026-03-23"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic retinal screening at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Chest X-ray, posteroanterior and lateral: mild hyperinflation; heart size normal; no pulmonary edema, effusion or consolidation",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "399208008",
            "display": "Plain X-ray of chest",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-10-20",
          "end": "2026-10-20"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic chest X-ray at the attack.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Resting 12-lead ECG: sinus tachycardia at 106 per minute; normal axis and intervals; no ischemic change",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "29303009",
            "display": "Electrocardiographic procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-10-20",
          "end": "2026-10-20"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ECG in a man with diabetes and breathlessness.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "PROC-007",
        "display": "Spirometry before and 15 minutes after albuterol 400 mcg, with FeNO, interpreted with GLI Global race-neutral equations: FEV1 2.95 L (77 percent predicted) rising to 3.42 L (+470 mL, +16 percent); FEV1/FVC 0.66 before and 0.75 after; FeNO 44 ppb. Reversible airflow obstruction: asthma",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "127783003",
            "display": "Spirometry",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-10-27",
          "end": "2026-10-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic diagnostic lung function testing.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "PROC-008",
        "display": "Written asthma action plan with peak flow zones (green above 470 L/min, yellow 300 to 470, red below 300, from his predicted value until a personal best is set), given and explained",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "716542004",
            "display": "Asthma action care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-10-27",
          "end": "2026-10-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic self-management plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "PROC-009",
        "display": "Inhaler technique with a spacer, taught and checked by teach-back: correct",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "710957008",
            "display": "Assessment of inhalation technique",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-10-27",
          "end": "2026-10-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic technique check.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Influenza vaccine, this season",
        "status": "completed",
        "date": "2026-02-16",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccination for an adult with diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "COVID-19 mRNA vaccine, this season's formula",
        "status": "completed",
        "date": "2026-02-16",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "309",
            "display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal COVID-19 vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-02-16",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose for an adult 19 to 49 with diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Tdap vaccine (no record of a tetanus vaccine in adulthood)",
        "status": "completed",
        "date": "2026-03-09",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic catch-up Tdap.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 1 of 2",
        "status": "completed",
        "date": "2026-03-09",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis B vaccination for an adult with diabetes, given with screening tests drawn the same day.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "IMM-006",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 2 of 2",
        "status": "completed",
        "date": "2026-10-27",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic completion of the series after his return; screening showed no immunity.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "IMM-007",
        "display": "Influenza vaccine, the new season",
        "status": "completed",
        "date": "2026-10-27",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccination for the new season.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "IMM-008",
        "display": "COVID-19 mRNA vaccine, the new season's formula",
        "status": "completed",
        "date": "2026-10-27",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "309",
            "display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal COVID-19 vaccination for the new season.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "FAMMEMB",
          "display": "family member"
        },
        "condition": "Diabetes, which he called \"a hereditary foe\"; no relative is named and no detail is recorded",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      }
    ],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Diabetes, as he described it in his letters, after his return to India at about 34; physicians advised the cool air of Darjeeling and rest; he wrote that eating only meat and drinking no water seemed the only way to prolong his life; how it was diagnosed is not recorded",
        "historical_date": {
          "iso": "1897-03",
          "display": "March 1897",
          "precision": "month",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Lifelong difficulty falling asleep, in his own words: unable to sleep on getting into bed, tossing for at least two hours",
        "historical_date": {
          "iso": "1897-05-29",
          "display": "May 29, 1897",
          "precision": "day",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "New patient visit for thirst, frequent urination, tiredness and weight loss in a 35-year-old monk told of diabetes a year ago and never tested: examination, random glucose and urine tests, and planning of fasting tests to confirm and classify diabetes; long-standing insomnia; raised blood pressure",
        "status": "finished",
        "date": "2026-02-09",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Diagnosis visit with the endocrinology consultation: A1c, fasting glucose, GAD antibodies, C-peptide, urine albumin, lipids and B12; type 2 diabetes confirmed; metformin by shared decision; nutrition and fasting plans",
        "status": "finished",
        "date": "2026-02-16",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Diagnosis visit: fasting test results with the endocrinology consultation",
          "hpi": {
            "narrative": "Swami Vivekananda returns one week after his first visit, fasting since the evening meal, for blood tests drawn this morning and his consultation with Dr. Lindqvist-Bose. He is still thirsty and passes urine three times a night. He has drunk water freely as advised. A few days ago he kept the night-long fast of a major festival, without water until the next morning, and felt light-headed and very thirsty by dawn; he asked how he can keep his fasts safely. His home blood pressure readings over the week averaged 136/86. He wants to know what kind of diabetes this is and whether he will need injections.",
            "elements": [
              {
                "label": "Symptoms",
                "value": "Thirst; nocturia three times; tiredness; weight 72.8 kg"
              },
              {
                "label": "Fasting",
                "value": "A night-long waterless festival fast a few days ago, with light-headedness by dawn"
              },
              {
                "label": "Home blood pressure",
                "value": "Average 136/86 over seven days"
              },
              {
                "label": "His questions",
                "value": "What kind of diabetes, whether injections are needed, and how to keep his fasts"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired; weight down a further 0.2 kg"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Frequent urination, three times a night"
            },
            {
              "system": "Eyes",
              "status": "positive",
              "finding": "Reading vision blurred at times"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal pain, nausea or vomiting"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well, alert and forthright; weight 72.8 kg, BMI 24.6; blood pressure 136/86, pulse 80"
            },
            {
              "system": "Skin",
              "finding": "No acanthosis nigricans; mucous membranes moist"
            },
            {
              "system": "Feet",
              "finding": "Skin intact; pulses present; monofilament and vibration sense normal"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no edema"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Type 2 diabetes, new",
              "assessment": "Diabetes is confirmed by two abnormal results, A1c 9.4 percent and fasting glucose 172 mg/dL, with symptoms. GAD65 antibodies are negative and the fasting C-peptide of 2.6 ng/mL shows good insulin secretion, so this is type 2 diabetes, not type 1 or slowly progressive autoimmune diabetes; his urine had no ketones. South Asian people develop type 2 diabetes younger and at lower weights, which is why ADA screens Asian Americans from a BMI of 23; his BMI is 24.6. Insulin is not needed now: there is no ketosis, his own insulin is preserved and the A1c is below 10 percent. After discussing metformin alone, metformin with a second tablet, and an injected GLP-1 receptor agonist, he chose to start with metformin and diet and to review in five weeks",
              "plan": [
                "Metformin extended-release 500 mg with the evening meal for a week, then 1000 mg",
                "Home glucose meter: fasting reading daily, and during any fast",
                "Dietitian and diabetes education this week",
                "Target A1c below 7 percent"
              ]
            },
            {
              "display": "Religious fasting with diabetes",
              "assessment": "Fasting is his practice and his decision. Using IDF-DAR risk stratification adapted to his fasts, his risk is moderate: on metformin alone hypoglycemia is unlikely, but with glucose this high a fast without water risks dehydration, as he felt last week",
              "plan": [
                "Fortnightly fasts with fruit, milk and water are reasonable now; avoid fasts without water until his glucose is steady below 180 mg/dL",
                "Take metformin with the meal that ends a fast",
                "Check glucose at midday and before breaking the fast; break the fast if below 70 or above 300 mg/dL, or if dizzy, confused or vomiting"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Moderately increased albuminuria, first sample",
              "assessment": "Urine albumin-to-creatinine ratio 46 mg/g with a normal eGFR; it can rise with very high glucose, so it must be repeated twice over three to six months",
              "plan": [
                "Repeat at the next visit and in three months"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Raised blood pressure",
              "assessment": "Clinic 136/86 and home 136/86: hypertension is likely; with albuminuria the target is below 130/80",
              "plan": [
                "Decide on treatment at the preventive visit after another week of home readings"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Mixed hyperlipidemia",
              "assessment": "LDL 132, triglycerides 228 and HDL 36; triglycerides will fall as glucose improves",
              "plan": [
                "Discuss a statin at the preventive visit"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Insomnia",
              "assessment": "Lifelong difficulty falling asleep, worse with nocturia from high glucose",
              "plan": [
                "Sleep diary; cognitive behavioral therapy for insomnia referral"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Hyperglycemia with thirst and weight loss",
              "assessment": "Explained by the diagnosis made today; superseded",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "A1c and fasting glucose",
              "cadence": "At diagnosis; quarterly until at goal",
              "status": "completed_today",
              "detail": "A1c 9.4 percent; fasting glucose 172 mg/dL",
              "observation_ids": [
                "OBS-A1C-V2",
                "OBS-GLU-V2"
              ],
              "guideline_ids": [
                "GL-ADA-DX-2026",
                "GL-ADA-PHARM-2026",
                "GL-ADA-GLY-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Classification: GAD65 antibodies and C-peptide",
              "cadence": "At diagnosis when type 1 or autoimmune diabetes is possible (young, lean or weight loss)",
              "status": "completed_today",
              "detail": "GAD65 antibodies 1.2 IU/mL (negative); C-peptide 2.6 ng/mL (preserved); urine ketones negative last week",
              "observation_ids": [
                "OBS-GAD-V2",
                "OBS-CPEP-V2"
              ],
              "guideline_ids": [
                "GL-ADA-DX-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio and eGFR",
              "cadence": "At diagnosis, then yearly; two of three abnormal over three to six months to confirm",
              "status": "completed_today",
              "detail": "46 mg/g, moderately increased; eGFR 106 last week",
              "observation_ids": [
                "OBS-UACR-V2"
              ],
              "guideline_ids": [
                "GL-ADA-CKD-2026",
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "LDL 132, triglycerides 228, HDL 36",
              "observation_ids": [
                "OBS-CHOL-V2",
                "OBS-HDL-V2",
                "OBS-TG-V2",
                "OBS-LDL-V2"
              ],
              "guideline_ids": [
                "GL-ADA-CVD-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "ALT with FIB-4 (fatty liver screen) and TSH",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "ALT 38; FIB-4 0.6 (low risk); TSH 1.8",
              "observation_ids": [
                "OBS-ALT-V2",
                "OBS-TSH-V2"
              ],
              "guideline_ids": [
                "GL-ADA-DX-2026",
                "GL-ADA-PHARM-2026",
                "GL-ADA-GLY-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Vitamin B12",
              "cadence": "Periodically on long-term metformin; baseline because he eats mostly vegetarian food",
              "status": "completed_today",
              "detail": "312 pg/mL, normal",
              "observation_ids": [
                "OBS-B12-V2"
              ],
              "guideline_ids": [
                "GL-ADA-DX-2026",
                "GL-ADA-PHARM-2026",
                "GL-ADA-GLY-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure, weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "136/86; home 136/86; weight 72.8 kg, BMI 24.6",
              "guideline_ids": [
                "GL-ADA-CVD-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Comprehensive foot examination",
              "cadence": "At diagnosis, then yearly",
              "status": "completed_today",
              "detail": "Normal monofilament and vibration; pulses present",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Dilated eye examination or retinal photographs",
              "cadence": "At diagnosis, then every one to two years",
              "status": "ordered",
              "detail": "Retinal photographs booked for the next visit",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Diabetes self-management education and medical nutrition therapy",
              "cadence": "At diagnosis",
              "status": "referred",
              "detail": "Dietitian this week: a mostly vegetarian plan built on his monastery meals",
              "guideline_ids": [
                "GL-ADA-BEH-2026",
                "GL-SA-PLANT-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Fasting risk assessment and plan",
              "cadence": "Before any religious fast",
              "status": "completed_today",
              "detail": "Moderate risk; plan for fruit-and-milk fasts; no waterless fasts until glucose is steady",
              "guideline_ids": [
                "GL-IDF-DAR-2021",
                "GL-ADA-BEH-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hypoglycemia review",
              "cadence": "Every visit on insulin or a sulfonylurea",
              "status": "not_indicated",
              "detail": "Neither used; sulfonylureas avoided because of his fasting",
              "guideline_ids": [
                "GL-ADA-DX-2026",
                "GL-ADA-PHARM-2026",
                "GL-ADA-GLY-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Tobacco use",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None now",
              "guideline_ids": [
                "GL-ADA-DX-2026",
                "GL-ADA-PHARM-2026",
                "GL-ADA-GLY-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression, anxiety and diabetes distress",
              "cadence": "At diagnosis and yearly",
              "status": "up_to_date",
              "detail": "PHQ-2 0 last week; full screens at the preventive visit",
              "guideline_ids": [
                "GL-ADA-BEH-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Vaccinations",
              "cadence": "Yearly",
              "status": "completed_today",
              "detail": "Influenza, COVID-19 and PCV20 today; hepatitis B and Tdap at the preventive visit",
              "guideline_ids": [
                "GL-CDC-IMZ-MC-2026",
                "GL-CDC-IMZ-2026"
              ]
            }
          ],
          "follow_up": "Preventive visit in three weeks. Diabetes review in five weeks, with retinal photographs and the repeat urine albumin. Call for vomiting, abdominal pain, drowsiness or glucose above 300 mg/dL",
          "guideline_ids": [
            "GL-ADA-DX-2026",
            "GL-ADA-PHARM-2026",
            "GL-ADA-GLY-2026",
            "GL-ADA-CKD-2026",
            "GL-IDF-DAR-2021",
            "GL-SOUTHASIAN-2013",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Five-week diabetes review before a long journey: glucose log, metformin dose, kidney function and potassium on losartan, repeat urine albumin, retinal photographs, statin, and a travel and fasting plan",
        "status": "finished",
        "date": "2026-03-23",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Five-week diabetes review before a long journey",
          "hpi": {
            "narrative": "Swami Vivekananda returns five weeks after starting metformin and two weeks after starting losartan. His thirst has gone, he wakes to pass urine once a night or not at all, and his fasting readings are 128 to 150 mg/dL. He has had no dizziness on losartan; home blood pressure averages 128/80. He has seen the dietitian twice: he now takes a smaller portion of rice with more dal and vegetables, keeps the sweets offered after worship to a small piece, and has kept two fortnightly fasts with fruit, milk and water, with midday readings of 110 to 140 mg/dL. The screening tests from the preventive visit were negative for HIV, hepatitis C, hepatitis B surface antigen and tuberculosis infection, and he is not immune to hepatitis B. He has decided to take the statin. In a week he leaves for several months of travel and teaching in the mountains, and wants a plan he can follow far from the clinic.",
            "elements": [
              {
                "label": "Glucose",
                "value": "Fasting 128 to 150 mg/dL; midday on fast days 110 to 140 mg/dL"
              },
              {
                "label": "Blood pressure",
                "value": "Home average 128/80 on losartan"
              },
              {
                "label": "Screening results",
                "value": "HIV, hepatitis C antibody, hepatitis B surface antigen and interferon-gamma release assay negative; hepatitis B surface antibody negative"
              },
              {
                "label": "Upcoming",
                "value": "Several months of travel in the mountains from next week"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy much better; weight 73.8 kg"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "Nocturia once at most"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No loose stools"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Eager for the journey; sleep still slow to come"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 73.8 kg; blood pressure 128/80, pulse 74"
            },
            {
              "system": "Eyes",
              "finding": "Retinal photographs today: no retinopathy in either eye"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular; no edema"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Type 2 diabetes, improving",
              "assessment": "Improving on metformin 1000 mg and his changed diet, with fasting readings still above 130. He chose to increase metformin to the full dose. A second medicine (an SGLT2 inhibitor) was discussed; because his albuminuria is not yet confirmed, and because a new medicine that adds fluid loss is unwise at the start of months of travel with fasting, he chose to wait and decide on his return",
              "plan": [
                "Metformin extended-release 2000 mg with the evening meal",
                "A1c in three months: at a laboratory where he is staying, or a home kit, with results sent to the clinic",
                "Sick-day rules: hold metformin and losartan if vomiting, diarrhea or unable to drink, and restart when eating",
                "Enough medicine, test strips and a printed summary for the journey; message the clinic with readings monthly"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Moderately increased albuminuria",
              "assessment": "Second sample 41 mg/g; one more over three to six months will confirm it",
              "plan": [
                "Repeat in three months with the A1c"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Hypertension",
              "assessment": "Home 128/80 on losartan; potassium 4.6 and creatinine 1.00, stable",
              "plan": [
                "Continue losartan 25 mg"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Mixed hyperlipidemia",
              "assessment": "He chose a moderate-intensity statin",
              "plan": [
                "Atorvastatin 10 mg daily",
                "Lipid panel in six to twelve weeks"
              ]
            },
            {
              "display": "Fasting and travel",
              "assessment": "His fasts with fruit, milk and water have gone safely on metformin",
              "plan": [
                "Continue the same rules; with glucose now steady below 180, a short waterless fast is possible if he drinks well before and after, checks glucose, and breaks it by the same thresholds; avoid waterless fasts in heat or at high altitude"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Insomnia",
              "assessment": "Sleep diary: about two hours to fall asleep, five hours of sleep, rising before dawn for meditation; STOP-BANG 2 (low risk of sleep apnea). Insomnia Severity Index 15",
              "plan": [
                "Cognitive behavioral therapy for insomnia by video while he travels: a fixed rising time kept with his meditation, time in bed matched to sleep, and no reading or writing in bed",
                "No sleeping tablets, as he prefers"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "A1c",
              "cadence": "Quarterly until at goal and after a change in therapy",
              "status": "due",
              "detail": "Due in three months, during his travels; arrangements made",
              "guideline_ids": [
                "GL-ADA-DX-2026",
                "GL-ADA-PHARM-2026",
                "GL-ADA-GLY-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium and creatinine after starting an ARB",
              "cadence": "One to two weeks after starting or changing the dose",
              "status": "completed_today",
              "detail": "Potassium 4.6; creatinine 1.00; eGFR 101",
              "observation_ids": [
                "OBS-K-V4",
                "OBS-CR-V4",
                "OBS-EGFR-V4"
              ],
              "guideline_ids": [
                "GL-ADA-CKD-2026",
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio",
              "cadence": "Two of three abnormal over three to six months to confirm",
              "status": "completed_today",
              "detail": "41 mg/g, the second abnormal sample",
              "observation_ids": [
                "OBS-UACR-V4"
              ],
              "guideline_ids": [
                "GL-ADA-CKD-2026",
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel after starting a statin",
              "cadence": "Four to twelve weeks after starting",
              "status": "due",
              "detail": "Statin started today; due in six to twelve weeks",
              "guideline_ids": [
                "GL-ADA-CVD-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Retinal photographs",
              "cadence": "At diagnosis, then every one to two years",
              "status": "completed_today",
              "detail": "No retinopathy in either eye",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure, weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "128/80; home 128/80; weight 73.8 kg",
              "guideline_ids": [
                "GL-ADA-CVD-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Medical nutrition therapy",
              "cadence": "At diagnosis and as needed",
              "status": "completed_today",
              "detail": "Two dietitian visits; a mostly vegetarian plan of his choosing",
              "guideline_ids": [
                "GL-ADA-BEH-2026",
                "GL-SA-PLANT-2022"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Fasting plan",
              "cadence": "Before any religious fast",
              "status": "completed_today",
              "detail": "Fasts with fruit, milk and water went safely; travel rules agreed",
              "guideline_ids": [
                "GL-IDF-DAR-2021",
                "GL-ADA-BEH-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sick-day rules",
              "cadence": "At diagnosis and before travel",
              "status": "completed_today",
              "detail": "Hold metformin and losartan when vomiting, diarrhea or unable to drink",
              "guideline_ids": [
                "GL-ADA-DX-2026",
                "GL-ADA-PHARM-2026",
                "GL-ADA-GLY-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Tobacco use",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ADA-DX-2026",
                "GL-ADA-PHARM-2026",
                "GL-ADA-GLY-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Insomnia treatment",
              "cadence": "At diagnosis of chronic insomnia",
              "status": "referred",
              "detail": "Cognitive behavioral therapy for insomnia by video",
              "guideline_ids": [
                "GL-ACP-INS-2016",
                "GL-AASM-INS-2021"
              ]
            }
          ],
          "follow_up": "Messages with home readings monthly while he travels. A1c, urine albumin and lipid panel in about three months wherever he is. Diabetes review on his return",
          "guideline_ids": [
            "GL-ADA-PHARM-2026",
            "GL-ADA-GLY-2026",
            "GL-ADA-CKD-2026",
            "GL-ADA-CVD-2026",
            "GL-ADA-RETFOOT-2026",
            "GL-IDF-DAR-2021",
            "GL-ACP-INS-2016",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Review after seven months away and a week after an asthma attack: A1c, kidneys, lipids, spirometry with bronchodilator response and FeNO; asthma and diabetic kidney disease confirmed; empagliflozin and maintenance-and-reliever inhaler; fasting plan for the coming festival",
        "status": "finished",
        "date": "2026-10-27",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Review after seven months away, a week after an asthma attack",
          "hpi": {
            "narrative": "Swami Vivekananda returns a week after the sick visit for a moderate asthma attack, and nine days after coming home from seven months of travel in the mountains. He finished five days of prednisone three days ago; his glucose rose to 210 to 268 mg/dL before the evening meal during the course and came back to 120 to 140 fasting within two days, without other treatment. The nurse telephoned on the second day. He has used the budesonide-formoterol inhaler two to four times a day; he has woken twice in the week with tightness, and the attacks are milder. While away he took metformin 2000 mg, losartan and atorvastatin, messaged his fasting readings (110 to 135 mg/dL), and kept his fortnightly fasts with fruit and milk. He could not find a laboratory for the three-month blood tests, so they were not done. He completed four of six video sessions for insomnia and falls asleep within about 45 minutes on most nights. The festival of the goddess is in two weeks and he intends to keep its fast.",
            "elements": [
              {
                "label": "Asthma",
                "value": "Reliever two to four times a day; woken twice in a week; Asthma Control Test 15"
              },
              {
                "label": "Prednisone and glucose",
                "value": "Evening glucose 210 to 268 mg/dL during the course; settled within two days"
              },
              {
                "label": "While away",
                "value": "Fasting glucose 110 to 135 mg/dL; three-month laboratory tests not done"
              },
              {
                "label": "Sleep",
                "value": "Four video sessions of cognitive behavioral therapy for insomnia; about 45 minutes to fall asleep"
              },
              {
                "label": "Coming fast",
                "value": "A festival fast in two weeks"
              }
            ]
          },
          "ros": [
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Wheeze and tightness on two nights this week; cough in the mornings"
            },
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy returning; weight 74.8 kg"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or ankle swelling"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No nocturia; no urinary symptoms"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Cheerful; PHQ-2 1"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 74.8 kg, BMI 25.3; blood pressure 126/78, pulse 82; oxygen saturation 97 percent"
            },
            {
              "system": "Respiratory",
              "finding": "Faint expiratory wheeze on forced expiration"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular; no edema"
            },
            {
              "system": "Feet",
              "finding": "Skin intact after months of walking; no calluses or sores"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-009",
              "display": "Asthma, adult onset, confirmed",
              "assessment": "Asthma is confirmed: FEV1/FVC 0.66 rises to 0.75 after albuterol, with a 470 mL (16 percent) rise in FEV1, and FeNO 44 ppb shows type 2 inflammation. It began on his return to the damp plains and is not controlled (Asthma Control Test 15, night waking, a recent attack needing prednisone), so he needs maintenance treatment, not only a reliever. Read with race-neutral equations, his FEV1 is 77 percent of predicted",
              "plan": [
                "GINA track 1, step 3: budesonide-formoterol one inhalation twice daily and one as needed, up to 12 a day, with a spacer",
                "Written action plan; peak flow meter to set his personal best",
                "Smoke-free room; incense outside where he can",
                "Review in four to six weeks; repeat spirometry in three months"
              ]
            },
            {
              "problem_id": "PRB-010",
              "display": "Diabetic kidney disease, G1 A2",
              "assessment": "Moderately increased albuminuria on three samples over eight months (46, 41 and 34 mg/g) with an eGFR of 103 confirms diabetic kidney disease, stage G1 A2. It has fallen with better glucose and losartan, but persists. An SGLT2 inhibitor protects the kidneys and the heart and lowers glucose without hypoglycemia. He agreed to start it now, with clear rules for fasting and illness",
              "plan": [
                "Empagliflozin 10 mg each morning",
                "Skip empagliflozin on any day of fasting without water, and stop it and metformin when unable to eat or drink; drink well on fruit-and-milk fast days",
                "Watch for genital itching or soreness; keep the area clean",
                "Potassium, creatinine and urine albumin in three months, then every six months"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Type 2 diabetes, at target",
              "assessment": "A1c 6.9 percent on metformin, down from 9.4; prednisone raised his evening glucose briefly, as expected. The A1c due at three months was missed while he travelled",
              "plan": [
                "Continue metformin 2000 mg and add empagliflozin as above",
                "For the festival fast: metformin with the meal that ends the fast; empagliflozin taken on fruit-and-milk fast days but skipped on a waterless day; glucose at midday and before breaking the fast; break it if below 70 or above 300 mg/dL, or if dizzy or unwell",
                "A1c in three months"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Hypertension",
              "assessment": "126/78 on losartan; at target",
              "plan": [
                "Continue losartan 25 mg"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Mixed hyperlipidemia",
              "assessment": "LDL 84 and triglycerides 146 on atorvastatin 10 mg; the check due six to twelve weeks after starting was missed while he travelled",
              "plan": [
                "Continue atorvastatin 10 mg; lipids yearly"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Insomnia",
              "assessment": "Better with cognitive behavioral therapy; he wants to finish the course",
              "plan": [
                "Remaining two video sessions"
              ]
            },
            {
              "problem_id": "PRB-008",
              "display": "Attacks of wheeze and breathlessness",
              "assessment": "Explained by asthma, diagnosed today; superseded",
              "plan": [
                "Problem resolved"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Moderately increased albuminuria",
              "assessment": "Confirmed and now recorded as diabetic kidney disease",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "A1c",
              "cadence": "Quarterly until at goal and after a change in therapy",
              "status": "completed_today",
              "detail": "6.9 percent, at target",
              "observation_ids": [
                "OBS-A1C-V6",
                "OBS-GLU-V6"
              ],
              "guideline_ids": [
                "GL-ADA-DX-2026",
                "GL-ADA-PHARM-2026",
                "GL-ADA-GLY-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "A1c three months after the change in therapy",
              "cadence": "Quarterly after a change in therapy",
              "status": "deferred",
              "detail": "Missed: due three months after the metformin dose increase, while he was travelling in the mountains, and he could not find a laboratory. No harm resulted judging by today's A1c of 6.9 percent and his monthly fasting readings of 110 to 135 mg/dL. Corrective action: a point-of-care or mail-in A1c kit and a video visit are now arranged before any journey longer than two months",
              "guideline_ids": [
                "GL-ADA-DX-2026",
                "GL-ADA-PHARM-2026",
                "GL-ADA-GLY-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio, eGFR and potassium",
              "cadence": "To confirm albuminuria; then every six months at G1 A2; potassium on an ARB",
              "status": "completed_today",
              "detail": "34 mg/g, the third abnormal sample (46, 41, 34): diabetic kidney disease confirmed; eGFR 103; potassium 4.5",
              "observation_ids": [
                "OBS-UACR-V6",
                "OBS-CR-V6",
                "OBS-EGFR-V6",
                "OBS-K-V6"
              ],
              "guideline_ids": [
                "GL-ADA-CKD-2026",
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel after starting a statin",
              "cadence": "Four to twelve weeks after starting",
              "status": "deferred",
              "detail": "Missed: due six to twelve weeks after starting atorvastatin, during his travels; done today, seven months after starting: LDL 84, triglycerides 146. No harm resulted. Corrective action: as for the A1c, testing before long journeys is now planned",
              "observation_ids": [
                "OBS-CHOL-V6",
                "OBS-HDL-V6",
                "OBS-TG-V6",
                "OBS-LDL-V6"
              ],
              "guideline_ids": [
                "GL-ADA-CVD-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure, weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "126/78; weight 74.8 kg, BMI 25.3",
              "guideline_ids": [
                "GL-ADA-CVD-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Foot examination",
              "cadence": "Yearly; inspection after long walking",
              "status": "completed_today",
              "detail": "Intact; no calluses or sores",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "SGLT2 inhibitor safety: fasting, illness, genital infection and volume",
              "cadence": "At start and every visit",
              "status": "completed_today",
              "detail": "Fasting and sick-day rules given; genital hygiene advice; blood pressure 126/78; no orthostatic symptoms",
              "guideline_ids": [
                "GL-ADA-CKD-2026",
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026",
                "GL-IDF-DAR-2021",
                "GL-ADA-BEH-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Glucose during oral corticosteroids",
              "cadence": "During any steroid course",
              "status": "completed_today",
              "detail": "Evening glucose 210 to 268 mg/dL during prednisone; settled without insulin",
              "guideline_ids": [
                "GL-ADA-GLY-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Fasting plan",
              "cadence": "Before any religious fast",
              "status": "completed_today",
              "detail": "Plan for the festival fast in two weeks with empagliflozin and metformin",
              "guideline_ids": [
                "GL-IDF-DAR-2021",
                "GL-ADA-BEH-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Spirometry with bronchodilator response and FeNO",
              "cadence": "At diagnosis of asthma",
              "status": "completed_today",
              "detail": "FEV1 2.95 L (77 percent) to 3.42 L (+470 mL, +16 percent); FEV1/FVC 0.66 to 0.75; FeNO 44 ppb",
              "observation_ids": [
                "OBS-FEV1PRE-V6",
                "OBS-FEV1POST-V6",
                "OBS-FEV1P-V6",
                "OBS-RATIOPRE-V6",
                "OBS-RATIOPOST-V6",
                "OBS-FENO-V6"
              ],
              "guideline_ids": [
                "GL-GINA-2025",
                "GL-NAEPP-2020",
                "GL-CMID-2026",
                "GL-ATS-RACE-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Asthma Control Test, symptoms, night waking and reliever use",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Asthma Control Test 15; woken twice this week; reliever two to four times a day",
              "observation_ids": [
                "OBS-ACT-V6"
              ],
              "guideline_ids": [
                "GL-GINA-2025",
                "GL-NAEPP-2020",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Review within a week of an exacerbation",
              "cadence": "Within one to seven days after any exacerbation",
              "status": "completed_today",
              "detail": "Nurse call on day two; this review on day seven",
              "guideline_ids": [
                "GL-GINA-2025",
                "GL-NAEPP-2020",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Inhaler technique and action plan",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Technique correct with a spacer; written plan given",
              "guideline_ids": [
                "GL-GINA-2025",
                "GL-NAEPP-2020",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen",
              "cadence": "Yearly and as needed",
              "status": "completed_today",
              "detail": "PHQ-2 1",
              "observation_ids": [
                "OBS-PHQ2-V6"
              ],
              "guideline_ids": [
                "GL-ADA-BEH-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Vaccinations",
              "cadence": "Yearly",
              "status": "completed_today",
              "detail": "Influenza and COVID-19 for the new season; hepatitis B dose 2, delayed by his travel, completes the series",
              "guideline_ids": [
                "GL-CDC-IMZ-MC-2026",
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Insomnia treatment",
              "cadence": "Until the course is complete",
              "status": "completed_today",
              "detail": "Four of six sessions done; sleep onset about 45 minutes",
              "guideline_ids": [
                "GL-ACP-INS-2016",
                "GL-AASM-INS-2021"
              ]
            }
          ],
          "follow_up": "Asthma review in four to six weeks. Diabetes and kidney review with A1c, potassium, creatinine and urine albumin in three months. Call during the festival fast if glucose is below 70 or above 300 mg/dL. Next preventive visit in the spring",
          "guideline_ids": [
            "GL-ADA-PHARM-2026",
            "GL-ADA-CKD-2026",
            "GL-KDIGO-CKD-2024",
            "GL-IDF-DAR-2021",
            "GL-GINA-2025",
            "GL-NAEPP-2020",
            "GL-ATS-RACE-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Periodic preventive visit",
        "status": "finished",
        "date": "2026-03-09",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Preventive visit; three weeks on metformin",
          "billing_note": "CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning), CPT 90715 (Tdap), CPT 90739 (hepatitis B vaccine) and CPT 90471 and 90472 (vaccine administration), all on the same day",
          "health_risk_assessment_method": "Completed by the patient on paper before the visit and reviewed with him by Dr. Thornbury-Mensah",
          "hpi": {
            "narrative": "Swami Vivekananda, 35, comes for his preventive visit three weeks after diabetes was confirmed. He takes metformin extended-release 1000 mg with the evening meal; the loose stools of the first week have settled. His thirst has eased, he gets up to pass urine once a night instead of three times, and his fasting readings on the home meter are 138 to 162 mg/dL. He has seen the dietitian. His home blood pressure averaged 136/86 over seven days. He kept the fortnightly fast last week with fruit, milk and water, as planned, without symptoms. He still lies awake for about two hours before he falls asleep.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic preventive visit, age 35"
              },
              {
                "label": "Active conditions",
                "value": "Type 2 diabetes, new; moderately increased albuminuria, to be confirmed; raised blood pressure; mixed hyperlipidemia; long-standing insomnia"
              },
              {
                "label": "Medicines",
                "value": "Metformin extended-release 1000 mg with the evening meal"
              },
              {
                "label": "Home readings",
                "value": "Fasting glucose 138 to 162 mg/dL; blood pressure average 136/86"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Fair, and improving"
            },
            {
              "domain": "Psychosocial",
              "finding": "Lives in community with his brother monks and disciples; purposeful work; his faith and practice"
            },
            {
              "domain": "Tobacco",
              "finding": "No tobacco use now"
            },
            {
              "domain": "Alcohol and drugs",
              "finding": "None, by his vows (AUDIT-C 0)"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks by the river each morning and evening; rides when he can"
            },
            {
              "domain": "Nutrition",
              "finding": "Mostly vegetarian monastery meals with fish at some; fewer sweets since seeing the dietitian; fasts twice a month"
            },
            {
              "domain": "Sleep",
              "finding": "Two hours to fall asleep most nights; rises before dawn; five hours' sleep"
            },
            {
              "domain": "Diabetes distress",
              "finding": "Low; he regards the illness calmly but wants it understood"
            },
            {
              "domain": "Safety",
              "finding": "No firearms; no violence"
            },
            {
              "domain": "Travel",
              "finding": "Plans to spend the summer and autumn travelling in the mountains"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy better; weight steady at 73 kg after the earlier loss"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "Reading vision a little blurred when glucose was high, now clearer"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No mouth or gum problems"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations or ankle swelling"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Loose stools of the first week of metformin settled"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Gets up once a night to pass urine, down from three times"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No foot sores or skin infections"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling in the feet"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood steady; PHQ-9 3, from sleep and tiredness; GAD-7 2"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Robust and well; weight 73.4 kg, BMI 24.8; blood pressure 134/84, pulse 76"
            },
            {
              "system": "Head, eyes, ears, nose, and throat",
              "finding": "Teeth and gums healthy"
            },
            {
              "system": "Neck",
              "finding": "No thyroid enlargement"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; no edema"
            },
            {
              "system": "Integumentary",
              "finding": "No acanthosis nigricans; feet intact"
            },
            {
              "system": "Psychiatric",
              "finding": "Warm, forthright and engaged"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic preventive visit completed",
              "assessment": "Health risk assessment reviewed and a written prevention plan given. Depression, anxiety and alcohol screens are negative",
              "plan": [
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Hypertension, stage 1",
              "assessment": "Home average 136/86 confirms stage 1 hypertension. With diabetes and a urine albumin-to-creatinine ratio of 46 mg/g, the target is below 130/80 and an ARB protects the kidneys; an ARB is chosen over an ACE inhibitor so that a cough does not confuse matters",
              "plan": [
                "Losartan 25 mg daily",
                "Potassium and creatinine in two weeks",
                "Home readings continue; less salt in cooking"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Mixed hyperlipidemia",
              "assessment": "LDL 132 and triglycerides 228 at 35 with diabetes, South Asian ancestry, albuminuria and hypertension: a moderate-intensity statin is reasonable even before 40. He asked for time to think",
              "plan": [
                "Decision at the next visit"
              ]
            },
            {
              "display": "Screening for a man born in India",
              "assessment": "Hepatitis B and latent tuberculosis screening are recommended for people born where they are common; HIV and hepatitis C once in adulthood",
              "plan": [
                "Hepatitis B surface antigen, surface antibody and core antibody, interferon-gamma release assay, HIV and hepatitis C antibody drawn today",
                "Hepatitis B vaccine series started today; Tdap today"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure",
              "status": "completed_today",
              "detail": "134/84 in clinic; home 136/86; treatment started"
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-9 score 3; item 9 scored 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Anxiety screening",
              "status": "completed_today",
              "detail": "GAD-7 score 2",
              "guideline_ids": [
                "GL-USPSTF-ANX-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "AUDIT-C score 0",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Hepatitis B screening",
              "status": "ordered",
              "detail": "Born in a country where hepatitis B is common; drawn today",
              "guideline_ids": [
                "GL-USPSTF-HBV-2020"
              ]
            },
            {
              "service": "Latent tuberculosis infection screening",
              "status": "ordered",
              "detail": "Born in a country where tuberculosis is common; interferon-gamma release assay drawn today",
              "guideline_ids": [
                "GL-USPSTF-LTBI-2023"
              ]
            },
            {
              "service": "HIV and hepatitis C screening",
              "status": "ordered",
              "detail": "Once-in-adulthood tests drawn today with his agreement",
              "guideline_ids": [
                "GL-USPSTF-HIV-2019",
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "service": "Diabetes and cholesterol",
              "status": "up_to_date",
              "detail": "A1c 9.4 percent and lipids three weeks ago; under treatment",
              "guideline_ids": [
                "GL-ADA-DX-2026"
              ]
            },
            {
              "service": "Diabetic eye examination",
              "status": "ordered",
              "detail": "Retinal photographs booked for the next visit",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026"
              ]
            },
            {
              "service": "Colorectal and prostate cancer screening",
              "status": "not_indicated",
              "detail": "Not due at 35"
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "completed_today",
              "detail": "Tdap given; no adult record",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "completed_today",
              "detail": "HepB-CpG dose 1 of 2 (diabetes, age 19 to 59)",
              "guideline_ids": [
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "up_to_date",
              "detail": "PCV20 three weeks ago (diabetes)",
              "guideline_ids": [
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "service": "Influenza and COVID-19 vaccines",
              "status": "up_to_date",
              "detail": "Given three weeks ago",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Zoster vaccine",
              "status": "not_indicated",
              "detail": "From 50"
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, a brother monk of his order, recorded in the confidential part of the chart and not named here. He wants treatment for any illness he could recover from. If he were dying, he would want to be at the monastery, not in a hospital, with the rites of his tradition and with chanting, and without measures that would only prolong dying. He asked that the clinic respect his monastic practices and his fasting at the end of life as at other times. To be revisited at any change in his health and at least yearly.",
          "follow_up": "Potassium and creatinine with the diabetes review in two weeks, with retinal photographs and the screening results. Hepatitis B dose 2 in a month or on his return. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-CDC-IMZ-2026",
            "GL-CDC-IMZ-MC-2026",
            "GL-ADA-CVD-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for an asthma attack after returning from the mountains",
        "status": "finished",
        "date": "2026-10-20",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Attacks of breathlessness and wheeze, the worst last night, two days after returning from the mountains",
          "billing_note": "Problem-oriented office visit, established patient, with bronchodilator treatment, chest X-ray, ECG and reassessment in clinic",
          "hpi": {
            "narrative": "Swami Vivekananda returned two days ago from seven months of travel in the mountains. He was well in the dry, cool hills. For about three weeks, since coming down to the damp plains, he has had attacks of wheeze, cough and tightness lasting hours, mostly at night, and last night he sat up for most of the night feeling that he was suffocating. Smoke from the kitchen fires and incense make it worse. He has never had asthma diagnosed and has no inhaler. He has no fever, chest pain, ankle swelling or orthopnea between attacks, and no green sputum. He has taken metformin 2000 mg, losartan and atorvastatin throughout his travels; his fasting readings were 110 to 135 mg/dL, and 196 mg/dL this morning after a sleepless night.",
            "elements": [
              {
                "label": "Onset",
                "value": "Three weeks, since coming down to the plains; worst last night"
              },
              {
                "label": "Severity",
                "value": "Sat up most of the night; speaks in sentences today; peak flow 330 L/min"
              },
              {
                "label": "Context",
                "value": "Type 2 diabetes on metformin; no previous asthma diagnosis or inhaler"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Night cough; no fever, chest pain, edema or purulent sputum"
              },
              {
                "label": "Glucose",
                "value": "Fasting 110 to 135 mg/dL while travelling; 196 mg/dL this morning"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Exhausted after a sleepless night; no fever"
            },
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Wheeze, cough, chest tightness and breathlessness at night"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations at rest, orthopnea between attacks or ankle swelling"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No cold or sore throat"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired, sitting upright, speaking in full sentences; mild use of the neck muscles"
            },
            {
              "system": "Vital signs",
              "finding": "Pulse 108, respiratory rate 24, oxygen saturation 94 percent on room air, temperature 36.9 °C; peak flow 330 L/min (56 percent of predicted)"
            },
            {
              "system": "Respiratory",
              "finding": "Widespread expiratory wheeze with fair air entry; no crackles"
            },
            {
              "system": "Cardiovascular",
              "finding": "Tachycardic, regular; jugular venous pressure not raised; no edema"
            },
            {
              "system": "Reassessment after one hour",
              "finding": "After albuterol 4 puffs by spacer three times over an hour: peak flow 410 L/min (69 percent, a rise of 24 percent), oxygen saturation 96 percent, pulse 98, wheeze much reduced"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-008",
              "display": "Attacks of wheeze and breathlessness: probable asthma, moderate attack",
              "assessment": "A moderate attack of what is most likely asthma, beginning in adult life and brought on by the damp plains and smoke: peak flow 56 percent of predicted rising 24 percent with albuterol, oxygen saturation 94 percent, speaking in sentences. Heart failure and pneumonia are unlikely: no fever, edema or orthopnea, a normal jugular venous pressure, and a chest X-ray without edema or consolidation; the ECG shows only sinus tachycardia. Rapid influenza and COVID-19 tests are negative. Safe to go home with treatment",
              "plan": [
                "Prednisone 40 mg each morning for five days",
                "Budesonide-formoterol one inhalation as needed, up to 12 a day, with a spacer, until spirometry next week",
                "Emergency care or 911 for breathlessness at rest, inability to speak in sentences, blue lips or no relief from the inhaler",
                "Avoid kitchen smoke and incense in his room for now",
                "Review in one week with spirometry before and after bronchodilator and FeNO"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Type 2 diabetes",
              "assessment": "Prednisone will raise his glucose, mainly in the afternoon and evening, for the five days and a day or two after. He is not fasting this week",
              "plan": [
                "Check glucose before breakfast and before the evening meal while on prednisone",
                "Continue metformin; call if two readings are above 300 mg/dL or he cannot eat or drink, so that short-term insulin can be considered",
                "No religious fast while he is on prednisone and unwell, as he agreed"
              ]
            }
          ],
          "follow_up": "Review in one week with spirometry and FeNO; telephone call from the nurse in two days about breathing and glucose",
          "guideline_ids": [
            "GL-GINA-2025",
            "GL-NAEPP-2020",
            "GL-ADA-GLY-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic unscheduled sick visit anchored to his documented suffocating attacks of asthma on his return to Belur.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-02-09",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 172,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 73.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 138,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 86,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at presentation, average of two readings; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-02-16",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 172,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 72.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 136,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 86,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 80,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs, average of two readings; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-03-09",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 172,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 73.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 134,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 84,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 76,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit, average of two readings.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-03-23",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 172,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 73.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs, average of two readings; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-20",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 172,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 74.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 25.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 132,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 108,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 24,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.9,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 94,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs on arrival at the sick visit; after treatment in clinic pulse 98, respiratory rate 18 and oxygen saturation 96 percent.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:30:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-10-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 172,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 74.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 25.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 82,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs, average of two readings; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "A Hindu monk of a monastic order, under vows of renunciation and celibacy; head of the order and of its service mission; lives at the order's monastery by the river with his brother monks and young disciples; teaches daily classes on scripture and lectures widely",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic modern life anchored to his documented monastic vows, founding of the mission and life at the monastery.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Daily routine: rises before dawn for meditation and worship; teaching and correspondence through the day; often works late into the night. Travels often, in India and abroad, and is now planning a long journey in the mountains from the spring",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic routine anchored to his documented teaching and travel.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Diet: eats with the monastery, mostly vegetarian (rice, chapati, dal, vegetables, milk and yogurt, and sweets offered after worship), with fish at some meals by his own choice; keeps religious fasts on the eleventh day of each lunar fortnight and at major festivals, sometimes without water. A year ago he believed that eating only meat and drinking no water was the way to live with diabetes",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic diet history; the earlier advice is documented in his letter of March 1897, and the fasting pattern is synthetic. His diet and fasting are his to choose.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "No alcohol, by his vows; no tobacco use now; no drug use. Incense and smoke from the monastery kitchen fires",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic exposure history; his tobacco use in his own lifetime was not researched, and the record makes no claim about it.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Supports: his brother monks and disciples, who share his daily life; his faith and practice. He wants his care to fit his vows and his duties, and he alone decides it",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic supports; no real person is given a role in his care.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent; walks and rides; tires by evening for the last two months",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, warm, forceful and humorous; speaks with great clarity; frustrated by tiredness and broken nights; PHQ-2 0",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about his real mental state.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Two months of thirst, frequent urination, tiredness and about 4 kg weight loss in a 35-year-old Hindu monk of South Asian ancestry with a BMI of 24.7 and a random glucose of 246 mg/dL, told of diabetes a year ago and never tested or treated except by diet. Please confirm and classify the diabetes with the fasting tests drawn on the morning of your visit, and advise on treatment that fits his mostly vegetarian monastic diet, his religious fasts and his frequent travel",
        "urgency": "Within one week",
        "pertinent_history": "Thirst and nocturia three times a night for two months; weight down from about 77 to 73 kg; no vomiting, abdominal pain or drowsiness. Urine dipstick: glucose 3+, ketones negative, protein trace. He calls diabetes hereditary in his family; no relative is named. Eats mostly vegetarian monastery meals, with fish at some, and keeps fasts twice a month and at festivals, sometimes without water. No alcohol; no tobacco now. Lifelong difficulty falling asleep. Today: blood pressure 138/86, pulse 84, BMI 24.7; no acanthosis nigricans. Random glucose 246 mg/dL, creatinine 0.96 mg/dL, eGFR 106, potassium 4.3, hemoglobin 14.6",
        "questions": [
          "Is this type 2 diabetes, or type 1, slowly progressive autoimmune or another type, and which tests decide it?",
          "With symptoms and weight loss, does he need insulin now, or can he start with tablets?",
          "Which medicines best fit his religious fasts, his mostly vegetarian diet and long periods of travel?",
          "How should he keep his fasts safely, and when should he break a fast?",
          "How should the kidneys be protected, given any albuminuria and his raised blood pressure?",
          "What targets and monitoring do you advise, including lipids at 35 with South Asian ancestry?"
        ]
      },
      "consultant_note": {
        "history": "Swami Vivekananda, 35, a Hindu monk, is seen at the request of Dr. Thornbury-Mensah for two months of thirst, nocturia, tiredness and weight loss. He was told of diabetes a year ago and has managed it only by diet. He eats mostly vegetarian meals at his monastery, with fish at some, and keeps fasts twice a month and at major festivals; a few days ago a night-long waterless fast left him light-headed and very thirsty. He calls diabetes hereditary in his family. He prefers tablets to injections but will accept what is needed",
        "data_reviewed": "Dr. Thornbury-Mensah's intake note: random glucose 246 mg/dL; urine glucose 3+ without ketones; creatinine 0.96, eGFR 106; BMI 24.7; blood pressure 138/86. This morning, fasting: A1c 9.4 percent; plasma glucose 172 mg/dL; GAD65 antibodies 1.2 IU/mL (negative); C-peptide 2.6 ng/mL; urine albumin-to-creatinine ratio 46 mg/g; total cholesterol 214, HDL 36, triglycerides 228, LDL 132 mg/dL; ALT 38 U/L (FIB-4 0.6); TSH 1.8; vitamin B12 312 pg/mL. Home blood pressure average 136/86",
        "exam": [
          {
            "system": "General",
            "finding": "Well and forthright; BMI 24.6; blood pressure 136/86, pulse 80"
          },
          {
            "system": "Skin",
            "finding": "No acanthosis nigricans; mucous membranes moist"
          },
          {
            "system": "Feet",
            "finding": "Monofilament and vibration sense normal; pulses present"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-002",
            "display": "Type 2 diabetes",
            "assessment": "Question 1: diabetes is confirmed by two abnormal results (A1c 9.4 percent, fasting glucose 172 mg/dL). GAD65 antibodies are negative and his fasting C-peptide is preserved, so this is type 2 diabetes; slowly progressive autoimmune diabetes is unlikely, though antibodies should be rechecked if he loses weight again or needs rapidly escalating treatment. Monogenic diabetes is unlikely without a clear three-generation pattern. In South Asians type 2 diabetes appears earlier and at lower BMI, with more insulin resistance for a given weight, which is why ADA screens Asian Americans from a BMI of 23. Question 2: insulin is not needed now. He has no ketosis, his own insulin secretion is good and the A1c is below 10 percent; his weight loss reflects glucose spilling into the urine and should stop with treatment"
          },
          {
            "problem_id": "PRB-003",
            "display": "Moderately increased albuminuria, first sample",
            "assessment": "Question 5: 46 mg/g on one sample, which hyperglycemia can raise; it needs two of three abnormal samples over three to six months before diabetic kidney disease is diagnosed"
          },
          {
            "problem_id": "PRB-004",
            "display": "Raised blood pressure",
            "assessment": "Clinic and home readings of about 136/86: with diabetes and albuminuria the target is below 130/80"
          }
        ],
        "recommendations": [
          "Question 3: start metformin extended-release with the evening meal, 500 mg for a week, then 1000 mg, rising to 2000 mg if tolerated; extended-release taken with the meal that ends a fast suits his fasts. A second tablet now would also be reasonable at this A1c, but starting with metformin and diet and reviewing in about five weeks is safe and is his preference. Avoid sulfonylureas, which cause hypoglycemia during fasts. A GLP-1 receptor agonist is not the first choice for a man who has just lost weight unintentionally and prefers tablets",
          "Once albuminuria is confirmed, add an SGLT2 inhibitor for kidney and heart protection, with clear rules: skip it on waterless fast days and stop it when unable to eat or drink",
          "Question 4: by IDF-DAR risk stratification, adapted from Ramadan to his fasts, his risk is moderate while glucose is high and low on metformin once it is steady. Fasts with fruit, milk and water are reasonable now; avoid waterless fasts until glucose is steady below 180 mg/dL, and then keep them short and drink well before and after; check glucose at midday and before breaking a fast; break it if glucose is below 70 or above 300 mg/dL, or if he is dizzy, confused or vomiting",
          "Medical nutrition therapy with a dietitian: a mostly vegetarian plan built on his monastery meals (dal, vegetables, whole grains and yogurt, with smaller portions of rice and sweets), respecting his choices; healthy plant-based diets are associated with better cardiometabolic risk in South Asians",
          "Question 5: if home blood pressure stays at or above 130/80, an ARB (losartan) rather than an ACE inhibitor; potassium and creatinine one to two weeks after starting; repeat the urine albumin twice over three to six months",
          "Question 6: A1c target below 7 percent, A1c every three months until at target; retinal photographs and a foot examination at diagnosis; vitamin B12 periodically on metformin; a moderate-intensity statin is reasonable at 35 with diabetes, South Asian ancestry, albuminuria and raised blood pressure; hepatitis B and pneumococcal vaccines"
        ],
        "communication": "Discussed with Dr. Thornbury-Mensah the same day. The results and the reasons for each recommendation were explained to Swami Vivekananda, including why his fasts and his diet are his to decide and how the plan adapts to them. He decides who else receives this note",
        "follow_up": "Endocrinology review in three months, or sooner if glucose stays above 250 mg/dL, ketones appear or he loses weight again; Dr. Thornbury-Mensah continues primary care and shares the monitoring"
      },
      "guideline_ids": [
        "GL-ADA-DX-2026",
        "GL-ADA-PHARM-2026",
        "GL-ADA-GLY-2026",
        "GL-ADA-CKD-2026",
        "GL-ADA-CVD-2026",
        "GL-IDF-DAR-2021",
        "GL-SOUTHASIAN-2013",
        "GL-SA-PLANT-2022"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "He is thirsty, up at night to pass urine, tired and losing weight, and wants to know whether he truly has diabetes and what kind",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic concern anchored to his documented diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "He wants any treatment to fit his monastic life: his diet, his fasts and his travel",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic concern reflecting his documented monastic life.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "He has never been able to fall asleep easily, and broken nights now leave him exhausted",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic concern anchored to his documented insomnia.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Diabetes confirmed and classified within a week",
        "status": "completed",
        "target_date": "2026-02-16",
        "outcome": "Type 2 diabetes confirmed by A1c 9.4 percent and fasting glucose 172 mg/dL; GAD65 antibodies negative and C-peptide preserved",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "A1c below 7 percent without hypoglycemia, in a way that fits his diet and fasts",
        "status": "completed",
        "target_date": "2026-10-27",
        "outcome": "A1c 6.9 percent on metformin; no hypoglycemia; fasts kept safely",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic glycemic goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Blood pressure below 130/80",
        "status": "completed",
        "target_date": "2026-03-23",
        "outcome": "Home 128/80 and clinic 128/80 two weeks after starting losartan",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood pressure goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Albuminuria reduced and kidney function preserved",
        "status": "active",
        "target_date": "2027-01-26",
        "outcome": "Urine albumin-to-creatinine ratio down from 46 to 34 mg/g; eGFR 103; empagliflozin started",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Falling asleep within 30 minutes on most nights",
        "status": "active",
        "target_date": "2026-12-08",
        "outcome": "About 45 minutes after four of six sessions",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic sleep goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Endocrinology consultation in one week, the same day as fasting blood tests, to confirm and classify diabetes (A1c, fasting glucose, GAD antibodies, C-peptide), and advise on treatment that fits his diet, his religious fasts and his travel",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-DX-2026",
          "GL-ADA-PHARM-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic specialist consultation booked at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Diagnostic tests in one week, fasting: A1c, fasting plasma glucose, GAD65 antibodies, C-peptide, urine albumin-to-creatinine ratio, lipid panel, ALT, TSH and vitamin B12; urine ketones negative today; drink water freely while thirsty and avoid waterless fasts until the results are known; return the same day if vomiting, abdominal pain or drowsiness",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-DX-2026",
          "GL-ADA-PHARM-2026",
          "GL-CMID-2026",
          "GL-ADA-COMORB-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Home blood pressure readings twice daily for a week with a validated upper-arm cuff, because clinic readings are raised",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-CVD-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood pressure plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Insomnia: sleep diary for two weeks, screening for sleep apnea, and cognitive behavioral therapy for insomnia adapted to his pre-dawn meditation; no sleeping tablets, by his preference; nocturia to be reviewed once glucose is treated",
        "status": "completed",
        "guideline_ids": [
          "GL-ACP-INS-2016",
          "GL-AASM-INS-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic insomnia plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T13:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Metformin extended-release with the evening meal, titrated to 2000 mg, chosen by shared decision over early combination therapy or an injected GLP-1 receptor agonist; home glucose meter; diabetes education and medical nutrition therapy for a mostly vegetarian plan built on his monastery meals, his choices and his fasts; sulfonylureas avoided because of fasting",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-PHARM-2026",
          "GL-ADA-BEH-2026",
          "GL-SA-PLANT-2022",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic diabetes treatment decided at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "recorded_date": "2026-02-16"
      },
      {
        "id": "INT-006",
        "display": "Religious fasting plan adapted from IDF-DAR risk stratification: fasts with fruit, milk and water allowed; waterless fasts only once glucose is steady, with hydration; metformin with the meal that ends the fast; glucose checks at midday and before breaking the fast; break the fast below 70 or above 300 mg/dL or when unwell",
        "status": "completed",
        "guideline_ids": [
          "GL-IDF-DAR-2021",
          "GL-ADA-BEH-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic fasting plan decided at diagnosis; his fasts are his decision.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "recorded_date": "2026-02-16"
      },
      {
        "id": "INT-007",
        "display": "Vaccines for an adult with diabetes: influenza and COVID-19 each season, PCV20 once, hepatitis B (two doses) and Tdap",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-IMZ-MC-2026",
          "GL-CDC-IMZ-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "recorded_date": "2026-02-16"
      },
      {
        "id": "INT-008",
        "display": "Hypertension with albuminuria: losartan 25 mg daily (an ARB rather than an ACE inhibitor, to avoid cough), less salt, home readings, potassium and creatinine two weeks after starting",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-CVD-2026",
          "GL-ADA-CKD-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood pressure treatment decided at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "recorded_date": "2026-03-09"
      },
      {
        "id": "INT-009",
        "display": "Cardiovascular prevention: atorvastatin 10 mg daily at 35 with diabetes, South Asian ancestry, albuminuria and hypertension, by his choice; lipid panel six to twelve weeks after starting",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-CVD-2026",
          "GL-SOUTHASIAN-2013",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic statin decision.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "recorded_date": "2026-03-23"
      },
      {
        "id": "INT-010",
        "display": "Travel plan for months away: medicine and test-strip supply, sick-day rules (hold metformin and losartan when vomiting, with diarrhea or unable to drink), monthly messages with readings, and A1c, urine albumin and lipids at three months wherever he is",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-PHARM-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic travel plan decided before the journey.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "recorded_date": "2026-03-23"
      },
      {
        "id": "INT-011",
        "display": "Asthma attack in a man with diabetes: prednisone 40 mg for five days with glucose checks before breakfast and the evening meal and a call for readings above 300 mg/dL; as-needed budesonide-formoterol until spirometry; review within a week",
        "status": "completed",
        "guideline_ids": [
          "GL-GINA-2025",
          "GL-ADA-GLY-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic plan decided at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "recorded_date": "2026-10-20"
      },
      {
        "id": "INT-012",
        "display": "Diabetic kidney disease G1 A2: empagliflozin 10 mg each morning, skipped on waterless fast days and stopped with metformin when unable to eat or drink; losartan continued; potassium, creatinine and urine albumin in three months, then every six months",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-CKD-2026",
          "GL-KDIGO-CKD-2024",
          "GL-IDF-DAR-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011",
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic kidney protection decided when albuminuria was confirmed.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "recorded_date": "2026-10-27"
      },
      {
        "id": "INT-013",
        "display": "Asthma on GINA track 1, step 3: budesonide-formoterol one inhalation twice daily and as needed with a spacer, a written action plan, a smoke-free room, review in four to six weeks and spirometry in three months",
        "status": "completed",
        "guideline_ids": [
          "GL-GINA-2025",
          "GL-NAEPP-2020",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic asthma treatment decided when asthma was confirmed.",
          "author": "The Human Record generator",
          "created": "2026-11-06T14:00:00-05:00"
        },
        "recorded_date": "2026-10-27"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, CKD and asthma monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-DX-2026",
        "title": "2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1):S27-S49)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358893/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-PHARM-2026",
        "title": "9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358900/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-CKD-2026",
        "title": "11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358881/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-CVD-2026",
        "title": "10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358899/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-RETFOOT-2026",
        "title": "12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358886/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-BEH-2026",
        "title": "5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358898/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-GLY-2026",
        "title": "6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358894/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-COMORB-2026",
        "title": "4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358897/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-KDIGO-CKD-2024",
        "title": "KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease",
        "publisher": "Kidney Disease: Improving Global Outcomes (Kidney Int 2024;105(4S):S117-S314)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38490803/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-ACP-INS-2016",
        "title": "Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians",
        "publisher": "American College of Physicians (Ann Intern Med 2016;165(2):125-133)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/27136449/",
        "version_or_year": "2016"
      },
      {
        "guideline_id": "GL-AASM-INS-2021",
        "title": "Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline",
        "publisher": "American Academy of Sleep Medicine (J Clin Sleep Med 2021;17(2):255-262)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/33164742/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-SOUTHASIAN-2013",
        "title": "Gujral UP, et al. Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations. Ann N Y Acad Sci 2013;1281:51-63 (PMID 23317344)",
        "publisher": "Annals of the New York Academy of Sciences",
        "url": "https://pubmed.ncbi.nlm.nih.gov/23317344/",
        "version_or_year": "2013"
      },
      {
        "guideline_id": "GL-IDF-DAR-2021",
        "title": "Hassanein M, et al. Diabetes and Ramadan: Practical guidelines 2021. Diabetes Res Clin Pract 2022;185:109185 (PMID 35016991)",
        "publisher": "International Diabetes Federation and the Diabetes and Ramadan International Alliance",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35016991/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-USPSTF-ANX-2023",
        "title": "Anxiety Disorders in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/anxiety-adults-screening",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-HIV-2019",
        "title": "Human Immunodeficiency Virus (HIV) Infection: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-USPSTF-HBV-2020",
        "title": "Hepatitis B Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-USPSTF-LTBI-2023",
        "title": "Latent Tuberculosis Infection in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CDC-IMZ-MC-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-GINA-2025",
        "title": "Global Strategy for Asthma Management and Prevention, 2025 update",
        "publisher": "Global Initiative for Asthma",
        "url": "https://ginasthma.org/reports/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-NAEPP-2020",
        "title": "2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group",
        "publisher": "National Heart, Lung, and Blood Institute (J Allergy Clin Immunol 2020;146(6):1217-1270)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/33280709/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-ATS-RACE-2023",
        "title": "Bhakta NR, et al. Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement. Am J Respir Crit Care Med 2023;207(8):978-995 (PMID 36973004)",
        "publisher": "American Thoracic Society",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36973004/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-SA-PLANT-2022",
        "title": "Bhupathiraju SN, et al. A healthy plant-based diet is favorably associated with cardiometabolic risk factors among participants of South Asian ancestry. Am J Clin Nutr 2022;116(4):1078-1090 (PMID 35731596)",
        "publisher": "American Journal of Clinical Nutrition",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35731596/",
        "version_or_year": "2022"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the classification as type 2 diabetes (GAD antibodies negative, C-peptide preserved, no ketosis), metformin alone at diagnosis with an A1c of 9.4 percent by his choice, the delay of the SGLT2 inhibitor until albuminuria was confirmed, losartan for stage 1 hypertension with albuminuria, the statin at 35, the adapted IDF-DAR fasting plan, the missed three-month A1c and post-statin lipid checks while he travelled, the prednisone course in a man with diabetes, and asthma on GINA track 1."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "He died in 1902; the recent-death rule does not apply. Claims rest on the Belur Math biography, three chapters of Swami Nikhilananda's biography, and seven of his own letters in the Complete Works (via Wikisource). His diabetes (1897), insomnia (1897), asthma (1898 to 1901) and albuminuria are documented in his own words; the classification of his diabetes, his kidney disease and the cause of his death are R."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "No mental health or substance claim is made; mood screens are synthetic and negative. His monastic life, diet and fasts are described with respect and left to his choice. His death is recorded once, with the physicians' and the monks' understandings side by side. No disciple, brother monk or other real person is named or given a role in the modern episode."
    }
  }
}
